Expression of the pan B-cell marker CD20 by T-cell lymphoproliferative disorders is exceedingly rare. We present a 52-year-old man with a unilesional cutaneous CD20 + T-cell lymphoproliferative disorder. Multispectral imaging analysis of CD3-CD20 double-stained lesional tissue sections allowed (1) the visualization of double-positive T lymphocytes in situ with sensitivity superior to that of conventional immunohistochemistry and (2) the quantitative assessment of marker coexpression. Here, 23% of CD3 + signals in the patient's lesion were also CD20 + , whereas 38% of CD20 + signals were also CD3 + . In contrast, both parameters were below 1% in the tonsil control. Overall, the percentage of doublepositive cells in lesional skin was 35%, although only 0.4% of such cells were detected in the tonsil. This is the first demonstration of aberrant CD20 expression by skin-infiltrating T cells using multispectral imaging.
INTRODUCTION
Expression of the human B-lymphocyte differentiation antigen CD20 is generally restricted to normal and neoplastic B cells and therefore provides a valuable tool in distinguishing B-cell lymphomas from T-cell lymphomas (TCLs). Furthermore, CD20 represents a therapeutic target in the management of B-cell malignancies, such as diffuse large B-cell lymphoma and chronic lymphocytic leukemia. TCLs with aberrant CD20 positivity have been occasionally described; however, the majority of such cases involve extracutaneous peripheral TCLs. 1-3 CD20 2 expressing cutaneous TCLs remain exceedingly rare with only 20 cases of CD20 + mycosis fungoides (MF) published to date. 4 Here, we present the first case of a CD20 + clinically benign cutaneous T-cell lymphoproliferative disorder (CTCLPD). To the best of our knowledge, this is also the first report of using multispectral imaging (MI) to aid in the visualization and quantitation of aberrant expression of CD20 by skin-infiltrating T lymphocytes.
CASE REPORT
A 52-year-old man presented to his dermatologist with a 2-month history of a 2-cm erythematous plaque on the right shoulder. Biopsy revealed epidermal spongiosis with parakeratosis and acanthosis, and a dense band-like lymphoid infiltrate with prominent epidermotropism and occasional Pautrier microabscess-like collections of lymphocytes within the epidermis (Figs. 1B-D). Single-stain immunohistochemistry (IHC) showed that the infiltrate was primarily composed of T cells (CD3 and CD4 + ) with fewer CD20 + cells, most of which appeared PAX5 2 but CD3 + (Figs. 1E-H). These findings suggested the possibility of MF with aberrant CD20 expression, prompting a referral to our Cutaneous Lymphoma Clinic for further evaluation and treatment.
Physical examination of the lesion revealed a 2-cm erythematous plaque with a central hemorrhagic crust (Fig. 1A ). Review of systems was unremarkable, and except for pruritus of the affected area, the patient denied other symptoms. Medical history was notable for type 2 diabetes, hypertension, hyperlipidemia, and epilepsy, which necessitated the long-standing use of divalproex sodium, simvastatin, hydrochlorothiazide, metoprolol succinate, clonazepam, mesalamine, thioridazine, glyburide, pioglitazone, and folic acid. Complete blood count with differential showed mild lymphocytosis (3600/mL) in the absence of other pathological findings. Rebiopsy demonstrated features similar to the previous biopsy, showing most notably a dermal band-like infiltrate composed mainly of lymphocytes, many of which had slightly large, hyperchromatic nuclei with occasional mitoses, and slightly spongiotic epidermis with focal clusters of lymphocytes. Molecular analysis of T-cell receptor gamma chain and immunoglobulin heavy chain gene rearrangements did not detect a dominant T-cell or B-cell clone. Extended immunophenotyping was inconclusive, showing the following profile: CD2 + , CD3 + , CD4 + , CD5 + , CD7 + , CD8 (,10%), CD30 (,1%). A CD3-CD20 dual stain was performed to corroborate the tentative diagnosis of CD20 + CTCLPD.
MATERIALS AND METHODS
CD3-CD20 dual staining of formalin-fixed paraffinembedded lesional tissue and formalin-fixed paraffin-embedded tonsil control tissue was performed using CD3 (clone 2GV6; Ventana, Tucson, AZ), CD20 (clone L26; Ventana), the Ventana BenchMark XT automated stainer, and ultraView DAB and Red detection kits (Ventana) in accordance with the manufacturer's protocols.
The double-stained slides were analyzed with the Nuance MI system (Perkin Elmer, Waltham, MA). Multispectral image cubes of relevant areas on each slide were acquired in bright-field mode at 20 nm intervals from 420 to 720 nm, using a full CCD frame at 1 · 1 binning. A spectral library containing the characteristic wavelength emission curves of diaminobenzidine (DAB), red, and hematoxylin was created by sampling spectra from tissue sections stained with single chromogens. Green, red, and blue pseudocolors were assigned to visualize DAB, red, and hematoxylin, respectively. Using the spectral library as reference, the Nuance 3.0.2 software measured the amount of target signal per pixel, subsequently generating pseudocolored composite images, which were further unmixed into individual components. Nonspecific background staining was eliminated by setting appropriate thresholds for each component (pixels with signals equal to or below background were ignored). The software determined the amount of CD3-CD20 colocalization within each image, and a colocalization mask was applied to visualize the double-positive pixels. Data were displayed as percentage of CD20 positivity within CD3 positivity and vice versa. To calculate the percentage of double-positive cells, the previously captured image cubes were used to train inForm 1.4 software (a patternrecognition image analysis software, part of the Nuance system software package) to distinguish epithelial versus nonepithelial areas and to segment the cells into nuclear and cytoplasmic compartments. Subsequently, inForm determined the percentage of double-positive cells within each image cube. Figure 1I shows a low-power image of CD3-CD20 double-stained lesional skin, demonstrating strong expression of both markers by the infiltrating cells. The brown DAB stain (CD3) and the red stain (CD20) appeared to be colocalized in at least some areas of the lesion. Figure 2A depicts a representative area of putative double positivity at higher magnification. The difficulty of discerning the stains by the unaided eye prompted us to subject the slide to MI analysis. The computer-generated image composite of user-assigned false colors (green replacing DAB, red replacing pink) facilitated the interpretation of the dual stain by significantly increasing the visual contrast between the 2 chromogens (Fig. 2B) . The system also allowed us to view CD3 and CD20 expression individually (Figs. 2C, D, respectively) and to capture the image of both markers without the counterstain ( Fig. 2E ). FIGURE 2. The MI system uses the unique spectral curves of each chromogen to convert the standard light microscopic image into a pseudo-colored composite image, which can be unmixed into individual components. A, Standard light microscopic image of a representative area of the CD3-CD20 double-stained section. B, Computer-generated composite depicts CD3, shown here in the user-assigned pseudocolor green, and CD20, shown in red; these colors were chosen to facilitate the visual differentiation of the markers. The counterstain is shown in blue, it appears darker in areas of spatial overlap with the green pseudocolor. C, CD3 only. D, CD20 only. E, CD3 and CD20, the counterstain is eliminated. F, Yellow colocalization mask indicates areas of CD3-CD20 double positivity.
RESULTS
Marker colocalization was also visualized by applying a "colocalization mask" to the composite, highlighting all pixels containing both chromogens in yellow (Fig. 2F) Quantitative data provided by the Nuance software revealed that 23% of the CD3 + signals in the patient's lesion were also positive for CD20, whereas CD3 was detected within 38% of CD20 + signals. In contrast, both parameters were below 1% in the tonsil tissue. Moreover, inForm software analysis showed that lesional skin contained 35% double-positive cells, although only 0.4% of such cells were detected in the tonsil.
DISCUSSION
CD20 is a 33 kD transmembrane phosphoprotein believed to function as an ion channel, thereby allowing the influx of calcium necessary for B-cell activation, proliferation, and differentiation. 5, 6 High-level (bright) CD20 expression is a feature of most normal and neoplastic B lymphocytes, whereas T cells, basophils, plasma cells, and nonhematopoietic cells are usually CD20 2 . Nevertheless, low-level (dim) CD20 expression by bone marrow-derived T cells and peripheral blood T cells is well-documented. 7-9 CD20 2 expressing CD3 + cells have also been observed in bone marrow specimens from patients with multiple myeloma and acute/chronic myelogenous leukemia. 7 T-cell malignancies, predominantly extracutaneous TCLs classified as peripheral T-cell lymphoma not otherwise specified, occasionally express CD20. [1] [2] [3] 10, 11 However, CD20 + CTCLPDs are extraordinarily rare. 4 The 20 cases reported in the English literature can be summarized as follows: (1) all patients suffered from various stages of MF, (2) 50% experienced a progressive clinical course with tumor formation and/or large cell transformation, (3) monoclonal rearrangement of the T-cell receptor-g gene was identified in 14 cases, and (4) the infiltrate included CD3 + lymphocytes, which also expressed CD20 (all cases) but lacked at least 1 typical B-cell marker like Pax5 or CD79a (14 cases). 4 Early-stage MF commonly poses a diagnostic challenge due to the overlap of clinical and microscopic features with a wide range of other lymphoproliferative disorders and inflammatory dermatoses. Accurate assessment therefore depends on the correlation of histopathologic, immunologic, and molecular parameters with clinical findings. In our case, molecular studies did not demonstrate clonality, and the extended IHC profile was inconclusive. In the view of these findings, and given the resolution in response to 2 triamcinolone acetonide injections and the lack of new lesions at 2-year follow-up, we favor the diagnosis of a CTCLPD lacking true malignant potential over that of MF. The patient's medications included several agents known to induce pseudolymphomatous skin reactions (clonazepam, divalproex sodium, hydrochlorothiazide, and thioridazine hydrochloride); however, these drugs were long-term agents without apparent temporal association with the current skin lesion. Thus, the underlying cause of the lymphoproliferative reaction described here remains undetermined.
Conventional IHC represents the gold standard for the detection of antigens in frozen and paraffin-embedded skin biopsies. Nearly all previously published reports of CD3-CD20 double-positive lymphocytes in lesional skin were based on serial single IHC stains, supplemented by a CD3-CD20 dual stain in 5 cases. 4, 12 Dual immunofluorescence was performed in 1 case, and 1 investigator used flow cytometry to demonstrate CD3-CD20 coexpression in T cells isolated from an involved lymph node. 4, 10 Ideally, the chromogens used for traditional microscopic observation of colocalization should provide optimal contrast between the individual colors and the mixed-color component. However, the few chromogen combinations that fulfill these requirements, such as beta-galactosidase activity in turquoise and alkaline phosphatase activity in red, are considered problematic due to technical challenges with resulting low sensitivity and/or inconsistent results. 13 The combination of horseradish peroxidase activity in brown and alkaline phosphatase activity in red has the advantage of ensuring 2 sensitive and efficient visualization procedures that produce a crisp microscopic appearance, but the unaided human eye cannot reliably discern red and brown in areas of color overlap because a distinct red-brown mixed color is lacking. 13 Nevertheless, redbrown is frequently used to demonstrate colocalization, as exemplified by all previously published images of CD3-CD20 double-positive cells in MF biopsies. 4, 12 In our case, the CD3-CD20 stain was difficult to interpret based on light microscopy alone: the infiltrate consisted predominantly of densely packed cells which stained strongly positive for both CD3 and CD20, and we were unable to differentiate the 2 chromogens in areas of presumed double positivity (Fig. 1) . To overcome this drawback, the double-stained slide was subjected to MI. MI systems measure light transmission at multiple wavelengths across the entire visible spectrum, allowing the accurate unmixing of spatially colocalized colors irrespective of their visual properties. 13, 14 Here, MI analysis enabled us to visualize CD3-CD20 double positivity and to quantitatively assess the percentage of double-positive T cells in the biopsied skin section. Our previous work showed that MI is useful for the detection of low-level expression of CD30 on neoplastic cells in MF lesions that are deemed CD30 2 by standard light microscopic observation. 15 The current report highlights an additional advantage of MI analysis over conventional light microscopy in the assessment of protein expression by T cells.
The significance of CD20 expression by T lymphocytes is yet to be elucidated. The increase in CD20 + T cells in the lymph nodes of monkeys upon stimulation with simian immunodeficiency virus and the expression of cell activation antigens CD38 and HLA-DR in a patient with CD20 + lymphoma/ leukemia support the hypothesis that CD20 acts as a T-cell activator. 3, 16, 17 Interestingly, the number of circulating CD20dim normal T cells increases with age, and it has been suggested that these cells might give rise to CD20 + TCLs. 9, 10 The efficacy of anti-CD20 antibodies, such as rituximab in the therapy of various B-cell malignancies, raises the possibility that recalcitrant CD20 + MF might also be amenable to this treatment. 4 CTCLPDs do not necessitate aggressive intervention; however, rare occurrences of lymphoma following the apparent resolution of a drug-induced benign lymphoproliferations have been observed. 18 The cases of CD20 + MF described so far indicate that CD20 expression might be associated with a poor clinical outcome 4 ; however, our case shows that CD20 expression can also be associated with clinically benign CTCLPDs.
